Evolent Common Stock Shares Outstanding from 2010 to 2024
| EVH Stock | USD 23.07 0.24 1.03% |
Common Stock Shares Outstanding | First Reported 2013-12-31 | Previous Quarter 113.6 M | Current Value 114.1 M | Quarterly Volatility 26.8 M |
Check Evolent Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Evolent main balance sheet or income statement drivers, such as Depreciation And Amortization of 129.6 M, Total Revenue of 2.1 B or Gross Profit of 483.5 M, as well as many exotic indicators such as Price To Sales Ratio of 1.78, Dividend Yield of 0.0072 or PTB Ratio of 3.61. Evolent financial statements analysis is a perfect complement when working with Evolent Health Valuation or Volatility modules.
Evolent | Common Stock Shares Outstanding |
Latest Evolent Health's Common Stock Shares Outstanding Growth Pattern
Below is the plot of the Common Stock Shares Outstanding of Evolent Health over the last few years. It is the total number of shares of a company's common stock that are currently owned by all its shareholders. Evolent Health's Common Stock Shares Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Evolent Health's overall financial position and show how it may be relating to other accounts over time.
| Common Stock Shares Outstanding | 10 Years Trend |
|
Common Stock Shares Outstanding |
| Timeline |
Evolent Common Stock Shares Outstanding Regression Statistics
| Arithmetic Mean | 55,869,072 | |
| Geometric Mean | 12,619,460 | |
| Coefficient Of Variation | 63.99 | |
| Mean Deviation | 29,788,268 | |
| Median | 64,351,000 | |
| Standard Deviation | 35,749,801 | |
| Sample Variance | 1278T | |
| Range | 111.2M | |
| R-Value | 0.92 | |
| Mean Square Error | 205.4T | |
| R-Squared | 0.85 | |
| Slope | 7,373,175 | |
| Total Sum of Squares | 17892.7T |
Evolent Common Stock Shares Outstanding History
About Evolent Health Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Evolent Health income statement, its balance sheet, and the statement of cash flows. Evolent Health investors use historical funamental indicators, such as Evolent Health's Common Stock Shares Outstanding, to determine how well the company is positioned to perform in the future. Although Evolent Health investors may use each financial statement separately, they are all related. The changes in Evolent Health's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Evolent Health's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Evolent Health Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Evolent Health. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 111.3 M | 70.4 M |
Currently Active Assets on Macroaxis
When determining whether Evolent Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Evolent Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Evolent Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Evolent Health Stock:Check out the analysis of Evolent Health Correlation against competitors. For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Complementary Tools for Evolent Stock analysis
When running Evolent Health's price analysis, check to measure Evolent Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolent Health is operating at the current time. Most of Evolent Health's value examination focuses on studying past and present price action to predict the probability of Evolent Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolent Health's price. Additionally, you may evaluate how the addition of Evolent Health to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |
Is Evolent Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evolent Health. If investors know Evolent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evolent Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.26) | Revenue Per Share 19.283 | Quarterly Revenue Growth 0.496 | Return On Assets 0.0062 | Return On Equity (0.09) |
The market value of Evolent Health is measured differently than its book value, which is the value of Evolent that is recorded on the company's balance sheet. Investors also form their own opinion of Evolent Health's value that differs from its market value or its book value, called intrinsic value, which is Evolent Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evolent Health's market value can be influenced by many factors that don't directly affect Evolent Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evolent Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evolent Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evolent Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.